← SynDRA
DAPRODUSTAT
SynDRA canonical compound SYN0038196 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | EGLN1 |
|---|
| Mechanism of action | hypoxia inducible factor inhibitor |
|---|
All known targets
- EGLN1
- EGLN2
- EGLN3
- HIF1AN
- P4HTM
Mechanisms of action (all sources)
- EGLN2 INHIBITOR
- Hypoxia-inducible factor prolyl hydroxylase inhibitor
- P4HTM INHIBITOR
- EGLN1 INHIBITOR
- EGLN3 INHIBITOR
- hypoxia inducible factor inhibitor
ATC classes
- B03X · OTHER ANTIANEMIC PREPARATIONS
Cross-references
Synonyms
- duvroq
- GSK-1278863
- GSK1278863
- GSK-1278863A
- 1278863
- jesduvroq
- Jesduvroq
- UNII-JVR38ZM64B
- GSK 1278863
- JVR38ZM64B
- N-((1,3-Dicyclohexylhexahydro-2,4,6-trioxopyrimidin-5-yl)carbonyl)glycine
- Daprodustat [USAN:INN]
- Daprodustat(GSK1278863)
- Daprodustat (JAN/USAN/INN)
- GTPL8455
- Daprodustat (GSK1278863)
- CHEMBL3544988
- KS-00000M8Z
- EX-A1121
- BCP16766
- s8171
- AKOS027439964
- Glycine, N-((1,3-dicyclohexylhexahydro-2,4,6-trioxo-5-pyrimidinyl)carbonyl)-
- ZINC231226004
- CS-5453
- SB19761
- DB11682
- HY-17608
- J3.560.573H
- D10874
- JESDUVROQ
- Duvroq
- daprodustatum
- RefChem:59170
- DTXCID001767752
- Daprodustat?
- Jesduvroq (TN)
- Duvroq (TN)
Look up DAPRODUSTAT in the interactive SynDRA portal →